a magnifying glass

adobe pdf icon Analogic Corporation Announces Agreement for Anrad's Flat-Panel Digital Detectors


Analogic Corporation Announces Agreement for Anrad’s Flat-Panel Digital Detectors

PEABODY, Mass.–(BUSINESS WIRE)–May 17, 2007–Analogic
Corporation (NASDAQ: ALOG) announced today that Anrad Corporation, its
wholly owned subsidiary based in St. Laurent, Quebec, Canada, has
signed an agreement with Siemens AG to develop and supply digital
flat-panel X-ray detectors for next-generation Full-Field Digital
Mammography (FFDM) that are particularly suitable for use in digital breast tomosynthesis 
systems. Full-field digital mammography is a rapidly
growing area in women’s health care.

Anrad designs and manufactures for Original Equipment
Manufacturers (OEMs) state-of-the-art, direct-conversion, amorphous
Selenium-based, digital flat-panel X-ray detectors for cardiology,
mammography, and general radiology applications. With its proprietary
technology, Anrad is known for producing plates with very high
Detector Quantum Efficiency (DQE), fast acquisition and reading rates,
extremely low noise electronics, and ghost-free operation, enabling
superior image quality and high patient throughput.

Mervat Faltas, President of Anrad, said, “This agreement will help
put Anrad on track towards becoming a leading global supplier of
flat-panel detectors for full-field digital mammography.”

Ed Becker, President and Chief Operating Officer of Analogic,
noted, “Anrad’s proprietary amorphous Selenium technology is
especially well suited for tomosynthesis, a 3-D imaging technology
that is expected to enhance diagnostic capabilities by detecting
subtle lesions while reducing false positives and unnecessary

Analogic Corporation is a leading designer and manufacturer of

advanced health and security systems and subsystems sold primarily to

Original Equipment Manufacturers (OEMs). The Company is recognized

worldwide for advancing the state of the art in Computed Tomography
(CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging

(MRI), and Patient Monitoring. For more information, visit

Any statements in this press release about future expectations,
plans, and prospects for the Company, including statements about
orders for the Company’s products, statements about shipments and
installation of the Company’s products, and other statements
containing the words “believes,” “anticipates,” “plans,” “expects,”
and similar expressions, constitute forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by such
forward-looking statements as a result of various important factors,
including risks relating to technology development and
commercialization, risks in product development, limited demand for
the Company’s products, risks associated with competition,
uncertainties associated with regulatory agency approvals, competitive
pricing pressures, downturns in the economy, the risk of potential
intellectual property litigation, and other factors discussed in our
most recent quarterly report filed with the Securities and Exchange
Commission. In addition, the forward-looking statements included in
this press release represent the Company’s views as of May 17, 2007.
The Company anticipates that subsequent events and developments will
cause the Company’s views to change. However, while the Company may
elect to update these forward-looking statements at some point in the
future, the Company specifically disclaims any obligation to do so.
These forward-looking statements should not be relied upon as
representing the Company’s views as of any date subsequent to May 17,

Analogic Corporation
Paul M. Roberts
Director of Communications
(978) 326-4213

Ed Becker
President & COO
(978) 326-4000

Analogic Corporation